When.com Web Search

  1. Ads

    related to: what are the new treatments available for copd

Search results

  1. Results From The WOW.Com Content Network
  2. A new drug developed by a company with US headquarters in Raleigh, Ohtuvayre, was approved by the FDA Wednesday to help COPD patients manage symptoms.

  3. Can drugs like Ozempic help with COPD? - AOL

    www.aol.com/drugs-ozempic-help-copd-070000493.html

    A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than those taking DPP-4 drugs.

  4. The Most Exciting New Advances in Managing COPD - AOL

    www.aol.com/lifestyle/most-exciting-advances...

    For people with COPD—and their care providers—the future looks bright. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us. Mail ...

  5. Ensifentrine - Wikipedia

    en.wikipedia.org/wiki/Ensifentrine

    Ensifentrine, sold under the brand name Ohtuvayre, is a medication used for the treatment of chronic obstructive pulmonary disease (COPD) in adults. [1] It is a phosphodiesterase 3 inhibitor and phosphodiesterase 4 inhibitor. [1] It is given by inhalation. [1] PDE3 inhibitors act as bronchodilators, while PDE4 inhibitors have an anti ...

  6. Fluticasone furoate/umeclidinium bromide/vilanterol - Wikipedia

    en.wikipedia.org/wiki/Fluticasone_furoate/...

    The combination fluticasone furoate/umeclidinium bromide/vilanterol product is approved by the US Food and Drug Administration with an indication for the maintenance treatment of a chronic lung problem called chronic obstructive pulmonary disease (COPD) in adults who (1) have already tried fluticasone furoate/vilanterol (brand name Breo Ellipta) but are still experiencing symptoms of airway ...

  7. Long-acting beta-adrenoceptor agonist - Wikipedia

    en.wikipedia.org/wiki/Long-acting_beta...

    This product was approved by the FDA in May 2013 as once-daily inhaled therapy for the treatment of chronic obstructive pulmonary disease (COPD) with umeclidinium bromide: Anoro Ellipta. Umeclidinium bromide is a long-acting muscarinic antagonist. [14]

  1. Ads

    related to: what are the new treatments available for copd